Who
Jeffrey A. Altman
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Anterix; 10% owner, Pyxus International; 10% owner, Constellation Acquisition Corp I; 10% owner, Estrella Immunopharma; 10% owner, Leo Holdings Corp. II; 10% owner, WinVest Acquisition; 10% owner, OneMedNet; 10% owner, Minority Equality Opportunities Acquisition.
In numbers
- Trades disclosed
- 45
- Buys
- 14
- Sells
- 10
- Bought
- $14.7M
- Sold
- $17.0M
- Companies
- 16
- Companies where not an officer
- 16
- First trade
- 7 Oct 2011
- Last trade
- 4 Aug 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Aug 2026filed 6 Aug 2026 | ATEX AnterixTelecom Carriers | SEC FORM 4 Code A | —1,598 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | ATEX AnterixTelecom Carriers | SEC FORM 4 Code A | —1,598 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | Pyxus International | SEC FORM 4 Bought | $911K325,374 at $2.80 | filing |
| 11 Jun 2024filed 13 Jun 2024 | Pyxus International | SEC FORM 4 Bought | $346K123,544 at $2.80 | filing |
| 1 Dec 2023filed 1 Dec 2023 | ATEX AnterixTelecom Carriers | SEC FORM 4 Bought | $214K6,407 at $33.41 | filing |
| 1 Dec 2023filed 1 Dec 2023 | ATEX AnterixTelecom Carriers | SEC FORM 4 Bought | $1.3M38,058 at $33.99 | filing |
| 30 Nov 2023filed 1 Dec 2023 | ATEX AnterixTelecom Carriers | SEC FORM 4 Bought | $955K29,727 at $32.11 | filing |
| 29 Nov 2023filed 1 Dec 2023 | ATEX AnterixTelecom Carriers | SEC FORM 4 Bought | $1.6M50,000 at $32.15 | filing |
| 6 Oct 2023filed 10 Oct 2023 | Constellation Acquisition Corp I | SEC FORM 4 Sold | $2.7M250,000 at $10.88 | filing |
| 29 Sep 2023filed 5 Oct 2023 | ESLA Estrella ImmunopharmaBiotechnology | SEC FORM 4 Code J | $2.8M255,000 at $10.86 | filing |
| 15 Sep 2023filed 18 Sep 2023 | Leo Holdings Corp. II | SEC FORM 4 Sold | $6.7M613,358 at $10.88 | filing |
| 15 Sep 2023filed 18 Sep 2023 | WinVest AcquisitionFunds, Shells & SPACs | SEC FORM 4 Sold | $4.9M450,000 at $10.80 | filing |
| 11 Aug 2023filed 21 Aug 2023 | ONMD OneMedNetLife-science tools | SEC FORM 4 Code J | $5.2M465,000 at $11.13 | filing |
| 3 Jul 2023filed 5 Jul 2023 | Minority Equality Opportunities Acquisition | SEC FORM 4 Code J | $3.4M310,000 at $10.91 | filing |
| 30 May 2023filed 1 Jun 2023 | OceanTech Acquisitions I | SEC FORM 4 Code J | $3.3M300,925 at $10.84 | filing |
| 22 May 2023filed 23 May 2023 | Progress Acquisition | SEC FORM 4 Code J | $2.7M257,300 at $10.40 | filing |
| 17 May 2023filed 19 May 2023 | Goldenbridge Acquisition | SEC FORM 4 Code J | $5.3M485,000 at $10.84 | filing |
| 1 May 2023filed 2 Jun 2023 | Parabellum Acquisition | SEC FORM 4 Code J | $4.7M462,333 at $10.26 | filing |
| 13 Apr 2023filed 20 Apr 2023 | Blue Safari Group Acquisition | SEC FORM 4 Code J | $3.3M306,648 at $10.89 | filing |
| 20 Mar 2023filed 23 Mar 2023 | ZURA Zura BioBiotechnology | SEC FORM 4 Code J | $5.7M550,000 at $10.40 | filing |
News
Anterix Inc. (NASDAQ:ATEX) Stock Has Average Price Target of $120.00ATEX · dailypolitical.com · 16 Oct 2026
0 headlines in the last 90 days name Jeffrey A. Altman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.